Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Metzger

Showing results (161-170 of 168) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 168 results.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 8, 2015
Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058David S Metzger, Deborah Donnell, David D Celentano, et al.
American Journal of Public Health|April 24, 2014
All-cause, cardiovascular, and cancer mortality in western Alaska Native people: western Alaska Tribal Collaborative for Health (WATCH)Barbara V Howard, Jesse S Metzger, Kathryn R Koller, et al.
AIDS and Behavior|January 15, 2021
HIV Infection and Depression Among Opiate Users in a US Epicenter of the Opioid EpidemicCecile M Denis, Tiffany Dominique, Peter Smith, et al.
AIDS (London, England)|November 30, 2020
Depressive symptoms and use of HIV care and medication-assisted treatment among people with HIV who inject drugsOleksandr Zeziulin, Katie R Mollan, Bonnie E Shook-Sa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2024
A randomized study of 6 versus 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapseJ-Y Blay, C Schiffler, O Bouché, et al.
Open Forum Infectious Diseases|August 30, 2021
Engaging People Who Inject Drugs Living With HIV in Antiretroviral Treatment and Medication for Opioid Use Disorder: Extended Follow-up of HIV Prevention Trials Network (HPTN) 074Kathryn E Lancaster, Katie R Mollan, Brett S Hanscom, et al.
Lancet (London, England)|September 8, 2018
A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy studyWilliam C Miller, Irving F Hoffman, Brett S Hanscom, et al.
JAMA|July 13, 2016
Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical TrialLisa R Metsch, Daniel J Feaster, Lauren Gooden, et al.
Pageof 17

Showing results (161-170 of 168) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 168 results.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 8, 2015
Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058David S Metzger, Deborah Donnell, David D Celentano, et al.
American Journal of Public Health|April 24, 2014
All-cause, cardiovascular, and cancer mortality in western Alaska Native people: western Alaska Tribal Collaborative for Health (WATCH)Barbara V Howard, Jesse S Metzger, Kathryn R Koller, et al.
AIDS and Behavior|January 15, 2021
HIV Infection and Depression Among Opiate Users in a US Epicenter of the Opioid EpidemicCecile M Denis, Tiffany Dominique, Peter Smith, et al.
AIDS (London, England)|November 30, 2020
Depressive symptoms and use of HIV care and medication-assisted treatment among people with HIV who inject drugsOleksandr Zeziulin, Katie R Mollan, Bonnie E Shook-Sa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2024
A randomized study of 6 versus 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapseJ-Y Blay, C Schiffler, O Bouché, et al.
Open Forum Infectious Diseases|August 30, 2021
Engaging People Who Inject Drugs Living With HIV in Antiretroviral Treatment and Medication for Opioid Use Disorder: Extended Follow-up of HIV Prevention Trials Network (HPTN) 074Kathryn E Lancaster, Katie R Mollan, Brett S Hanscom, et al.
Lancet (London, England)|September 8, 2018
A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy studyWilliam C Miller, Irving F Hoffman, Brett S Hanscom, et al.
JAMA|July 13, 2016
Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical TrialLisa R Metsch, Daniel J Feaster, Lauren Gooden, et al.
Pageof 17